Helichrysum in Jojoba
Natural health product licensed in Canada
- Other names
- Helichrysum 10% in Jojoba 5ml
- Licence holder
- Essential Nature Inc.
- NPN or DIN-HM
- 80084339
- Status
- Active licence
- Licence date
- 10 April 2018
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Huile de jojoba
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | minimum: 1 Goutte(s) ; maximum: 12 Goutte(s) | minimum: 1 Tous les jours ; maximum: 3 Tous les jours |
Uses authorised in Canada
Used in aromatherapy for symptomatic relief of acne, relief of minor skin irritations and bruises, symptomatic relief of eczema and dermatitis, as a calmative, to help relieve joint pain associated with rheumatoid arthritis and muscle pain associated with sprains, as a carminative for symptomatic relief of digestive discomfort, and to help relieve coughs.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Centre. Keep out of reach of children. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use. Avoid exposure of applied area(s) to the sun.
- Contre-indications
Do not use if pregnant or breastfeeding.
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
Source
Official Health Canada record, licence 80084339
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.